Difference between revisions of "Part:BBa K2201241"
| Line 18: | Line 18: | ||
<div class="figure small"> | <div class="figure small"> | ||
| − | + | https://static.igem.org/mediawiki/2017/f/f0/T--Bielefeld-CeBiTec--YKE_OD_after_irradiation.png | |
<p class="figure subtitle"><b>Figure 1:</b> OD<sub>600</sub> of three biological and three technical replicated of the <i>crtI</i> variants after cultivation.<p> | <p class="figure subtitle"><b>Figure 1:</b> OD<sub>600</sub> of three biological and three technical replicated of the <i>crtI</i> variants after cultivation.<p> | ||
</div> | </div> | ||
| Line 25: | Line 25: | ||
<div class="figure small"> | <div class="figure small"> | ||
| − | + | https://static.igem.org/mediawiki/2017/9/95/T--Bielefeld-CeBiTec--YKE_lycopene8.png | |
<p class="figure subtitle"><b>Figure 2:</b> Absorption spectrum of the four samples of the <i>crtI</i> variants, cultivated with AzoF supplemented to the media photoswitched to <i>cis</i>- or <i>trans</i>-conformation.<p> | <p class="figure subtitle"><b>Figure 2:</b> Absorption spectrum of the four samples of the <i>crtI</i> variants, cultivated with AzoF supplemented to the media photoswitched to <i>cis</i>- or <i>trans</i>-conformation.<p> | ||
</div> | </div> | ||
| Line 32: | Line 32: | ||
<div class="figure small"> | <div class="figure small"> | ||
| − | + | https://static.igem.org/mediawiki/2017/f/f0/T--Bielefeld-CeBiTec--YKE_switch_proof.png | |
<p class="figure subtitle"><b>Figure 3:</b> Absorption at 476 nm (indicator for lycopene) normalized to the OD<sub>600</sub> (indication for the cell density) to calculate the relative lycopene production of each <i>crtI</i> variant cultivated with AzoF in <i>cis</i>- and <i>trans</i>-conformation. | <p class="figure subtitle"><b>Figure 3:</b> Absorption at 476 nm (indicator for lycopene) normalized to the OD<sub>600</sub> (indication for the cell density) to calculate the relative lycopene production of each <i>crtI</i> variant cultivated with AzoF in <i>cis</i>- and <i>trans</i>-conformation. | ||
</div> | </div> | ||
Revision as of 19:01, 30 October 2017
CrtEBI under constitutive promoter with an amber codon at amino acid position 318 of crtI
This parts contains the part BBa_K274110 with an amber codon at position 318 of the crtI enzyme. With the help of an photoinducable amino acid crtI can be regulated by irradiation with light.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 2037
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 1573
Illegal NgoMIV site found at 1703
Illegal AgeI site found at 788 - 1000COMPATIBLE WITH RFC[1000]
Functional Parameters
To investigate the influence of photoswitching on the lycopene production, we cultivated three biological replicates of the three variants and each with one of the AzoF conformations for 24 hours in a 6-wellplate at 37 °C and 400 rpm. The media was supplemented with 1 mM of AzoF and then split in to charges. Both were irradiated for 40 minutes and 100 % brightness, one with 367 nm and the other with 465 nm to photoswitch the amino acids. After the cultivation, we measured the OD600 of each sample (Figure 1). The growth was not influenced in a noticeable way by the different AzoF variants, since the error bars overlap each other.
Figure 1: OD600 of three biological and three technical replicated of the crtI variants after cultivation.<p> </div> We then extracted the lycopene from the cell pellet and measured the lycopene amount (Figure 2). It can be seen that the TAG353 variant with the trans-AzoF has the highest lycopene production, followed by the TAG353 with the cis-AzoF and TAG318 with the trans-AzoF nearly equal. The TAG318 variant with the cis-AzoF has the lowest lycopene amount.
<p class="figure subtitle">Figure 2: Absorption spectrum of the four samples of the crtI variants, cultivated with AzoF supplemented to the media photoswitched to cis- or trans-conformation.<p>
The absorption at 476 nm was measured and normed to the OD600 of the samples. The relative lycopene production of each crtI and AzoF variant is shown in Figure 3 compared to the unmodified lycopene producer.
<p class="figure subtitle">Figure 3: Absorption at 476 nm (indicator for lycopene) normalized to the OD600 (indication for the cell density) to calculate the relative lycopene production of each crtI variant cultivated with AzoF in cis- and trans-conformation.
Figure 3 shows the effect on the lycopene production based on the incorporation of photoswitched AzoF. The trans-conformation seems to favor the binding activity of the active site, while the cis-conformation seems to reduce the binding activity. The highest difference in the lycopene production is present at the TAG353 variant. Here the cotransformant shows a lycopene production similar to the unmodified lycopene producer when cultivated with trans-AzoF while the productivity is reduced to nearly a third when cultivated with cis-AzoF. The AzoF-variants do not seem to influence the lycopene production when no amber-codon is present in crtI. Concluding, we provided strong evidence that that the observed difference in lycopene production in the three variants is caused by the incorporation and photoswitching of AzoF.
</div>
</div>